What to expect to pay for Wegovy each month
Wegovy (semaglutide) list price is about $1,349 for a four-week supply without insurance, but most people do not pay that amount out of pocket. Monthly cost can range from $0 to $1,300+ depending on insurance coverage, plan formularies, prior authorization status, and whether you use manufacturer or patient assistance programs. Your actual monthly cost depends on your deductible, coinsurance, out-of-pocket maximum, and whether your plan covers GLP-1 agonists for chronic weight management. Programs like Novo Nordisk’s NovoCare Pathways, Medicare Part D gap strategies, and 340B or community pharmacy discounts can meaningfully lower what you pay.
Understanding your insurance and formulary for Wegovy
Because GLP-1 agonists like semaglutide are often under utilization management, your plan may require prior authorization or step therapy before approving coverage. If your insurer covers Wegovy, you will typically pay a copay or coinsurance tied to your plan tier rather than the full sticker price. High-deductible plans may shift more cost to you initially, while higher-tier plans often lower your share. When a drug is not on the formulary or requires a trial of lower-cost alternatives, you may face denials or need a written appeal from your clinician.
How Medicare Part D and private Medicare Advantage plans affect Wegovy cost
Medicare Part D plans cover many GLP-1 agonists, but details vary plan by plan depending on pharmacy networks, deductibles, and whether coverage is in the gap or catastrophic phase. In Medicare Advantage, formulary rules can be tighter and prior authorization more common. Using a Medicare Part D Low Income Subsidy or selecting plans with broader pharmacy formularies can reduce monthly Wegovy costs if you are eligible. Manufacturer copay cards or savings offers may not apply to Medicare beneficiaries, so check plan-specific rules and out-of-pocket risk.
Manufacturer coupons and patient assistance programs
Novo Nordisk provides copay assistance and savings offers for eligible commercially insured patients who do not qualify for public insurance. These programs typically lower your coinsurance or copay for a set number of fills, but they may not apply if you have Medicaid, Medicare, or certain government plans. Income-based patient assistance, foundation co-pay support, and 340B discounted medications at community health centers can all reduce monthly expenses for qualifying households. Confirm eligibility and copay limits before you fill, because programs update rules and income thresholds periodically.
Sample monthly cost breakdowns by coverage type
| Coverage type | Typical monthly cost to patient | Notes and variables |
|---|---|---|
| Employer plan with low coinsurance | $20–$60 | Depends on tier, deductible status, and prior authorization outcome. |
| High-deductible health plan before OOP max | $300–$1,300+ | Often full cash price until deductible is met; coupons may help. |
| Medicaid or fully covered plan | $0–$20 | Copays vary by state and pharmacy; prior authorization still possible. |
| Medicare Part D with gap coverage | $200–$500+ | Costs can spike in the coverage gap; catastrophic phase typically lowers share. |
| Uninsured or cash-pay | $1,300+ | List price less potential 340B or cash pricing at select pharmacies; manufacturer savings may not apply. |
Out-of-pocket maximums and total annual cost
Once you reach your plan’s out-of-pocket maximum, your insurance covers 100% of allowed costs for the rest of the year, which can sharply lower effective monthly Wegovy spend. If Wegovy is covered, your annual cost to you will be close to your OOP max plus any premiums, rather than the full drug price. Plans with higher premiums but lower coinsurance or OOP limits can reduce your long-run burden if you intend to use Wegovy long term. Compare total yearly cost, not just monthly copay, when choosing between plans or deciding whether to stay on a current plan.
How to lower your monthly Wegovy bill: practical steps
- Confirm coverage and prior authorization status with your plan before you fill.
- Use in-network pharmacies to reduce denial risk and cash-pay surprises.
- Ask your clinician for an appeal letter if prior authorization is denied due to medical necessity.
- Check eligibility for manufacturer copay cards, 340B pricing, or patient assistance programs.
- Review your plan’s formulary annually during open enrollment or qualifying life events.
- If on Medicare, compare Part D plans each year and consider Low Income Subsidy if eligible.
- Use a single pharmacy to build cash-pay pricing relationships and avoid surprise bills from out-of-network facilities.
Why list price is usually not your price
The $1,349 list price is a reference for cash-paying, uninsured, or underinsured patients and does not reflect negotiated rebates, 340B discounts, or insurer contracts. Because most people with commercial or public insurance never pay list price, focus on your expected copay or coinsurance as the practical metric. If you pay separately for the injection device, factor in that cost, too; some plans include the pen in the drug benefit, while others treat it as a supply or durable medical equipment charge. Ask your pharmacist and insurer for an estimate specific to your plan and pharmacy before you commit to a fill.
When prices change and how to stay informed
Wegovy pricing can change with formulary updates, new manufacturer offers, policy renewals, or shifts in your household income that affect patient assistance eligibility. Set a reminder to review your benefits annually and reconfirm coverage before refills. If your costs rise unexpectedly, contact your plan and your provider’s billing team; sometimes a simple appeal or plan switch the following year can restore affordable coverage. Long-term users who plan carefully can stabilize monthly expenses by choosing consistent pharmacies and leveraging manufacturer and 340B savings where allowed.